GLAND PHARMAChart is in uptrend . We can take position by taking small stoploss lets see
Disclaimer:- Invest at your own risk,, i am not register with Sebi.. This chart is according to my technical analysis which i learnt from past years
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
42.00 INR
7.72 B INR
56.42 B INR
77.70 M
About GLAND PHARMA LTD
Sector
CEO
Srinivas Sadu
Headquarters
Sangareddy
Website
Founded
1978
ISIN
INE068V01023
FIGI
BBG00Y2K95H9
Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. It offers injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, and ophthalmic solutions. The company was founded by P. V. N. Raju in 1978 and is headquartered in Sangareddy, India.
GLAND - Weekly AnalysisIn the Weekly Chart of GLAND ,
we can see that, after Applying FIBO, it has shown rejections at 0.38 levels which looks like a Cup & Handle Failure.
It is now trying to recover from 0.236 levels.
Expected momentum is shown in chart.
High conviction stock - GLANDCheck this stock which has made an all time low and high chances that it makes a "V" shaped recovery.
> Taking support at last years support or breakout level
> High chances that it reverses from this point.
> Volume dried up badly in last few months / days.
> Very high suspicion based analysis and
Gland PharmaPositional buy view...
Buy above 1600 or wait for major support zone.
Educational purpose for myself...
Better suggestion are welcome.
Gland Pharma cmp 1800.45 by Weekly Chart views since listedGland Pharma cmp 1800.45 by Weekly Chart views since listed
- Support Zone at 1650 to 1700 Price Band
- Weekly Support at 1650 > 1470 > 1190 with Resistance at 1975 > 2225 > 2445
- *Price below Rising Support Trendline might be a cause of concern to consider currently*
- *Descending Triangle Breako
Perfect Reversal Candidate Gland PharmaNSE:GLAND
if the stock closes above ₹2160, we can expect up move to the zone ₹2640 and ₹3000. Immediate support levels are around ₹2000,
If it goes below down ₹1850 then we can avoid this stock
Keep An Eye on Volume, if it cross 2200 zone with high volume then it's sign of strong bull
Gland PharmaPharmaceutical ingredients and injectable formulations are produced by Gland Pharma Ltd. It provides injectables in the form of dry powders, infusions, lyophilized vials, ampoules, pre-filled syringes, vials, and ophthalmic solutions.
Gland Pharma appears interesting at 1865. It has dropped from t
BREAKOUT confirmed with volume Here on Ride the bull rally , Target 2170
Any price between 1900- 1970 will surely give you an amount of ₹100 per share or plus .
Be smart ride the rally allocate your funds here .
# I LOVE GLAND AS A BUSINESS , LETS BE INVESTORS IN A GOOD BUSINESS NOT GAMBLERS
LAST CHANCE TO BUY GLAND AT THIS HEAVY DISCOUNT . GLAND @RocketGLAND is a very good company dealing in complex injectables and has its distribution gloabally in a B2B model across rich geographies of europe , australia , usa and others .
Recent sale of promoter shares might be a wrong signal to investors but actually it isnt it as the funds are being allocate
GLAND READY TO ROCKET AGAIN In a 1 day timeframe Gland is oversold as seen stochastic RSI . Fibonacci retracement shows buying range between 0.786 and .618 . Also stock price is near to the trend line . Confirming a buy signal with a potential target of 2170 .
For information purposes only do your own research before a trade
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GLAND is 1,748.20 INR — it has decreased by −1.71% in the past 24 hours. Watch GLAND PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange GLAND PHARMA LIMITED stocks are traded under the ticker GLAND.
GLAND stock has fallen by −4.70% compared to the previous week, the month change is a −0.45% fall, over the last year GLAND PHARMA LIMITED has showed a −3.84% decrease.
We've gathered analysts' opinions on GLAND PHARMA LIMITED future price: according to them, GLAND price has a max estimate of 2,150.00 INR and a min estimate of 1,360.00 INR. Watch GLAND chart and read a more detailed GLAND PHARMA LIMITED stock forecast: see what analysts think of GLAND PHARMA LIMITED and suggest that you do with its stocks.
GLAND reached its all-time high on Aug 12, 2021 with the price of 4,350.00 INR, and its all-time low was 861.50 INR and was reached on May 22, 2023. View more price dynamics on GLAND chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GLAND stock is 2.36% volatile and has beta coefficient of 0.32. Track GLAND PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is GLAND PHARMA LIMITED there?
Today GLAND PHARMA LIMITED has the market capitalization of 288.02 B, it has decreased by −1.22% over the last week.
Yes, you can track GLAND PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
GLAND PHARMA LIMITED is going to release the next earnings report on Feb 3, 2025. Keep track of upcoming events with our Earnings Calendar.
GLAND earnings for the last quarter are 9.90 INR per share, whereas the estimation was 11.30 INR resulting in a −12.42% surprise. The estimated earnings for the next quarter are 13.00 INR per share. See more details about GLAND PHARMA LIMITED earnings.
GLAND PHARMA LIMITED revenue for the last quarter amounts to 14.06 B INR, despite the estimated figure of 14.26 B INR. In the next quarter, revenue is expected to reach 15.72 B INR.
GLAND net income for the last quarter is 1.64 B INR, while the quarter before that showed 1.44 B INR of net income which accounts for 13.75% change. Track more GLAND PHARMA LIMITED financial stats to get the full picture.
Yes, GLAND dividends are paid annually. The last dividend per share was 20.00 INR. As of today, Dividend Yield (TTM)% is 1.14%. Tracking GLAND PHARMA LIMITED dividends might help you take more informed decisions.
GLAND PHARMA LIMITED dividend yield was 1.09% in 2023, and payout ratio reached 42.64%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 15, 2024, the company has 4.22 K employees. See our rating of the largest employees — is GLAND PHARMA LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLAND PHARMA LIMITED EBITDA is 12.76 B INR, and current EBITDA margin is 23.67%. See more stats in GLAND PHARMA LIMITED financial statements.
Like other stocks, GLAND shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLAND PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLAND PHARMA LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLAND PHARMA LIMITED stock shows the neutral signal. See more of GLAND PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.